Table 3. Summary of all clinical studies comparing the node detection rate (i.e., over the total number of patients) and node uptake rate (i.e., over the total number of sentinel lymph nodes detected).
| Author | Year | P/R | Patient | Nodes | Node detection rate (%) |
Node uptake rate (%) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue | ICG | 99mTc | Blue + ICG | ICG + 99mTc | Blue | ICG | 99mTc | Blue + ICG | Blue + 99mTc | ICG + 99mTc | ||||||
| Sugie (80) | 2015 | P | 821 | N/A | N/A | 97.2 | 97 | N/A | 99.8 | N/A | 93.3 | 90 | N/A | N/A | N/A | |
| Samorani (81) | 2015 | P | 301 | 589 | N/A | 98.7 | 95.4 | N/A | 98.7 | N/A | 99 | 77.7 | N/A | N/A | 76.7 | |
| Pitsinis (56) | 2015 | P | 50 | 87 | 96 | 96 | N/A | 96 | N/A | 96.6 | 100 | N/A | 96.6 | N/A | N/A | |
| Verbeek (82) | 2014 | P | 95 | 177 | N/A | 99 | N/A | N/A | 99 | 78 | 100 | 88 | N/A | N/A | N/A | |
| Ballardini (55) | 2013 | P | 134 | 246 | N/A | N/A | N/A | N/A | N/A | N/A | 99.6 | 93.9 | N/A | N/A | N/A | |
| Wishant (59) | 2012 | P | 99 | 242 | 99 | 100 | 91.3 | N/A | N/A | 78.9 | 83.1 | 64.5 | 95 | 73.1 | N/A | |
| Tagaya (57) | 2011 | P | 50 | N/A | N/A | 100 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Sugie (71) | 2010 | P | 411 | 950 | 93 | 99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Murawa (70) | 2009 | P | 30 | N/A | N/A | 96.7 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Kitai (78) | 2005 | P | 18 | 50 | N/A | 94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
P, prospective; R, retrospective; ICG, indocyanine green; 99mTc, technetium radioisotope; N/A, not available.